Critical role of RAGE and HMGB1 in inflammatory heart disease

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 2, 2016, Pages E155-E164

  Bangert, Anna ^a   Andrassy, Martin ^a   Müller, Anna Maria ^a   Bockstahler, Mariella ^a   Fischer, Andrea ^a   Volz, Christian H ^a   Leib, Christoph ^a   Göser, Stefan ^a   Korkmaz Icöz, Sevil ^a   Zittrich, Stefan ^b   Jungmann, Andreas ^a   Lasitschka, Felix ^a   Pfitzer, Gabriele ^b   Müller, Oliver J ^a   Katus, Hugo A ^a   Kaya, Ziya ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

AAV; Cytokines; Myocarditis

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; GLYCYRRHIZIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; PARVOVIRUS VECTOR; TOLL LIKE RECEPTOR; TROPONIN I; AUTACOID; FREUND ADJUVANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOLOGIC FACTOR; MATRIX METALLOPROTEINASE; PROTEIN BINDING; TROPONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CARDIOMYOPATHY; CONTROLLED STUDY; EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; FEMALE; HEART FUNCTION; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; INTRACELLULAR SIGNALING; MOUSE; MYOCARDITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; AUTOIMMUNE DISEASE; BIOPSY; BLOOD; CARDIAC MUSCLE; COMPLICATION; DEPENDOPARVOVIRUS; DOWN REGULATION; DRUG EFFECTS; FIBROSIS; GENETIC TRANSCRIPTION; GENETICS; HEART DISEASE; HEART FUNCTION TEST; IMMUNIZATION; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; UPREGULATION;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; AUTOIMMUNE DISEASES; BIOPSY; DEPENDOVIRUS; DOWN-REGULATION; FIBROSIS; FREUND'S ADJUVANT; HEART DISEASES; HEART FUNCTION TESTS; HMGB1 PROTEIN; IMMUNIZATION; IMMUNOLOGIC FACTORS; INFLAMMATION; INFLAMMATION MEDIATORS; MATRIX METALLOPROTEINASES; MICE, KNOCKOUT; MYOCARDITIS; MYOCARDIUM; NF-KAPPA B; PROTEIN BINDING; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TRANSCRIPTION, GENETIC; TROPONIN; UP-REGULATION;

EID: 84954494103     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1522288113     Document Type: Article

References (57)

1. Göser S, et al. (2006) Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 114(16):1693-1702.
2. Kaya Z, et al. (2001) Contribution of the innate immune system to autoimmune myocarditis: A role for complement. Nat Immunol 2(8):739-745.
3. Eriksson S, Halenius H, Pulkki K, Hellman J, Pettersson K (2005) Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies. Clin Chem 51(5):839-847.
4. Leuschner F, et al. (2008) Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction. Eur Heart J 29(16):1949-1955.
5. Oozawa S, et al. (2008) Effects of HMGB1 on ischemia-reperfusion injury in the rat heart. Circ J 72(7):1178-1184.
6. Andrassy M, et al. (2008) High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 117(25):3216-3226.
7. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ (2010) HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 28:367-388.
8. Andersson U, Tracey KJ (2011) HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 29:139-162.
9. Lotze MT, Tracey KJ (2005) High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev Immunol 5(4):331-342.
10. Limana F, et al. (2005) Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res 97(8):e73-e83.
11. Rossini A, et al. (2008) HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells. J Mol Cell Cardiol 44(4): 683-693.
12. Kitahara T, et al. (2008) High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc Res 80(1):40-46.
13. Kohno T, et al. (2009) Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. Cardiovasc Res 81(3):565-573.
14. Liu T, et al. (2015) Increased serum HMGB1 level may predict the fatal outcomes in patients with chronic heart failure. Int J Cardiol 184:318-320.
15. Volz HC, et al. (2012) HMGB1 is an independent predictor of death and heart transplantation in heart failure. Clin Res Cardiol 101(6):427-435.
16. Wang LJ, et al. (2011) Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure. Eur J Heart Fail 13(4):440-449.
17. Yan XX, et al. (2009) Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients. Atherosclerosis 205(2):544-548.
18. Lu L, et al. (2009) Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes. Atherosclerosis 206(2):540-545.
19. Koyama Y, et al. (2008) Soluble receptor for advanced glycation end products (RAGE) is a prognostic factor for heart failure. J Card Fail 14(2):133-139.
20. Kaya Z, et al. (2008) Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis. Circulation 118(20):2063-2072.
21. Bianchi ME (2007) DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 81(1):1-5.
22. Volz HC, Kaya Z, Katus HA, Andrassy M (2010) The role of HMGB1/RAGE in inflammatory cardiomyopathy. Semin Thromb Hemost 36(2):185-194.
23. Andrassy M, et al. (2011) HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction. J Intern Med 270(3):245-253.
24. Harris HE, Andersson U, Pisetsky DS (2012) HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol 8(4):195-202.
25. Yang H, Tracey KJ (2010) Targeting HMGB1 in inflammation. Biochim Biophys Acta 1799(1-2):149-156.
26. Wang F, et al. (2010) Fas (CD95) induces rapid, TLR4/IRAK4-dependent release of proinflammatory HMGB1 from macrophages. J Inflamm (Lond) 7:30.
27. Gardella S, et al. (2002) The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 3(10):995-1001.
28. Magna M, Pisetsky DS (2014) The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases. Mol Med 20:138-146.
29. Ramasamy R, Yan SF, Schmidt AM (2008) Stopping the primal RAGE reaction in myocardial infarction: Capturing adaptive responses to heal the heart? Circulation 117(25):3165-3167.
30. Vogel S, et al. (2015) Necrotic cell-derived high mobility group box 1 attracts antigenpresenting cells but inhibits hepatocyte growth factor-mediated tropism of mesenchymal stem cells for apoptotic cell death. Cell Death Differ 22(7):1219-1230.
31. Rojas A, et al. (2013) The receptor for advanced glycation end-products: A complex signaling scenario for a promiscuous receptor. Cell Signal 25(3):609-614.
32. Mollica L, et al. (2007) Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem Biol 14(4):431-441.
33. Zhai CL, et al. (2012) Glycyrrhizin protects rat heart against ischemia-reperfusion injury through blockade of HMGB1-dependent phospho-JNK/Bax pathway. Acta Pharmacol Sin 33(12):1477-1487.
34. Bierhaus A, et al. (2004) Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest 114(12):1741-1751.
35. Schmidt AM, Yan SD, Yan SF, Stern DM (2001) The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108(7):949-955.
36. van Zoelen MA, Achouiti A, van der Poll T (2011) RAGE during infectious diseases. Front Biosci (Schol Ed) 3:1119-1132.
37. Belinsky GS, et al. (2014) Patch-clamp recordings and calcium imaging followed by single-cell PCR reveal the developmental profile of 13 genes in iPSC-derived human neurons. Stem Cell Res (Amst) 12(1):101-118.
38. Horton CG, Pan ZJ, Farris AD (2010) Targeting Toll-like receptors for treatment of SLE. Mediators Inflamm 2010:498980.
39. Tian J, et al. (2007) Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8(5):487-496.
40. Dumitriu IE, et al. (2005) Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 174(12):7506-7515.
41. Semino C, Angelini G, Poggi A, Rubartelli A (2005) NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 106(2):609-616.
42. Chen Y, et al. (2008) RAGE ligation affects T cell activation and controls T cell differentiation. J Immunol 181(6):4272-4278.
43. Müller OJ, et al. (2006) Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors. Cardiovasc Res 70(1):70-78.
44. Müller OJ, Schinkel S, Kleinschmidt JA, Katus HA, Bekeredjian R (2008) Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats. Gene Ther 15(23):1558-1565.
45. Paulus AC, et al. (2014) Polyethylene wear particles induce TLR 2 upregulation in the synovial layer of mice. J Mater Sci Mater Med 25(2):507-513.
46. Urbonaviciute V, et al. (2008) Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: Implications for the pathogenesis of SLE. J Exp Med 205(13):3007-3018.
47. Yang H, et al. (2010) A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci USA 107(26):11942-11947.
48. Bianchi R, Kastrisianaki E, Giambanco I, Donato R (2011) S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release. J Biol Chem 286(9):7214-7226.
49. Sakaguchi M, et al. (2011) TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding. PLoS One 6(8):e23132.
50. Bierhaus A, et al. (2001) Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50(12):2792-2808.
51. Krüger M, Pfitzer G, Stehle R (2003) Expression and purification of human cardiac troponin subunits and their functional incorporation into isolated cardiac mouse myofibrils. J Chromatogr B Analyt Technol Biomed Life Sci 786(1-2):287-296.
52. al-Hillawi E, Minchin SD, Trayer IP (1994) Overexpression of human cardiac troponin-I and troponin-C in Escherichia coli and their purification and characterisation. Two point mutations allow high-level expression of troponin-I. Eur J Biochem 225(3):1195-1201.
53. Grimm D, Kay MA, Kleinschmidt JA (2003) Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6 Mol Ther 7(6):839-850.
54. Andrassy M, et al. (2012) HMGB1 is associated with atherosclerotic plaque composition and burden in patients with stable coronary artery disease. PLoS One 7(12): e52081.
55. Yamada S, Yakabe K, Ishii J, Imaizumi H, Maruyama I (2006) New high mobility group box 1 assay system. Clin Chim Acta 372(1-2):173-178.
56. Schüffler PJ, et al. (2013) TMARKER: A free software toolkit for histopathological cell counting and staining estimation. J Pathol Inform 4(Suppl):S2.
57. Andrassy M, et al. (2006) Posttranslationally modified proteins as mediators of sustained intestinal inflammation. Am J Pathol 169(4):1223-1237.